CANCELED: Institutional Biosafety Committee Meeting - October 14, 2025
The Institutional Biosafety Committee (IBC) advises the Center on the handling of biohazardous materials, and reviews and approves research projects that involve biohazardous materials, including but not limited to recombinant or synthetic nucleic acid molecules.
The following meeting was canceled and will be rescheduled at a later date:
Title: Western Fisheries Research Center Institutional Biosafety Committee Meeting
Date: October 14, 2024
Time: 1-2pm PST
Persons wishing to attend may do so through Microsoft Teams: Link to meeting
Relevant documents sent to IBC members via email
Agenda:
Call to Order
State Member Conflicts if Any
Review Previous Minutes
- Minutes from the April 22, 2024 meeting have been previously reviewed and approved.
Old Business
- None
New Business
- Change application for Dr. Paul Hershberger
- Brief update on effluent treatment system (Thorough update on new monitoring system will occur winter 2025)
- Addressing “Strengthened Institutional Biosafety Committee Transparency” guidelines provided by NIH in March 2025.
Public Comment Period
Adjourn
Note:
Comments from the public and WFRC staff are to follow the guidelines outlined in the approved Charter:
6.4. Meeting attendance: Convened meetings of the IBC are open to the General Public, WFRC scientists, relevant partners, etc., in accordance with the NIH Guidelines. Non-IBC members may attend the meeting, but may not be part of the discussions, voting, or deliberation during the IBC meeting. They may not vote on any application. At the end of each meeting, non-IBC members will be given two (10) minutes to address the IBC. More time may be provided depending upon the number of non-IBC members wishing to speak and at the discretion of the IBC Chair. Written comments are also welcome, submitted to the IBC chair after the meeting. Non-IBC members may address topics not related to the application(s) being discussed. The Chair will be responsible for aggregating and distributing all written information received to the IBC.
6.4.1. Principal Investigators are welcome to attend IBC meetings and will be specifically invited to attend when their research is novel or especially complex when the IBC determines that the IBC would benefit from a full description of the proposed activities.